Archives

by in
Entry Author Date Location
San Diego Life Sciences Roundup: Receptos IPO, Isis, Versant, & More 04/12/13 San Diego
Ann Arbor’s Compendia Bioscience Acquired by Life Technologies 10/09/12 Detroit
Ziopharm Awaits Cancer Drug Data as Wall Street Withholds Judgment 08/29/12 New York
Actinium Advances Armed Cancer Drugs, Preps for Wall Street Debut 08/01/12 New York
Pet Dogs Help Biotech Startups Find New Weapons to Fight Cancer 07/25/12 San Diego
ImmunoGen Emerges from Genentech’s Shadow With Novel Cancer Drugs 07/12/12 Boston
Bristol-Myers Wrangles Top Academics to Study Immunity in Cancer 06/07/12 New York
FDA Rejects Ariad/Merck Sarcoma Pill, Wall Street Unfazed 06/06/12 New York
Bayer Oncology Dubs ASCO “Turning Point” for Cancer Efforts 06/06/12 New York
Merck Oncology Chief Heads to ASCO With High Hopes for New Drugs 05/31/12 New York
Genentech, Roche Find New Balance Three Years Post-Merger 05/29/12 San Francisco
The 2012 New York ASCO Checklist 05/24/12 New York
NY’s Cancer Research Institute Looks to Boost Cancer Immunotherapy 05/09/12 New York
Mersana Adds $4M For Next-Generation “Armed” Cancer Drugs 05/01/12 Boston
Ariad and Merck Face Tough FDA Review of Sarcoma Pill 03/20/12 Boston
Molecular Health Sets up in NYC With Personalized Med Tools 03/07/12 New York
FDA Gives Thumbs-Up to Skin Cancer Drug from Genentech and Curis 01/30/12 Boston
Celgene Buys Avila for $350M, Gaining Promising “Covalent” Drugs 01/26/12 Boston
Foundation Medicine and Sanofi Form Cancer Discovery Pact 01/10/12 Boston
Xconomy Storms NYC: Top Ten Topics in the Big Apple in 2011 12/27/11 New York
Metamark Inks Potential $365M Deal with J&J For Cancer Marker Discovery 12/19/11 Boston
Coronado Biosciences Debuts on Nasdaq, Moves Two Lead Drugs Forward 12/19/11 Boston
Cerulean Pharma Adds $15M to Further Nano-Drug Platform 12/15/11 Boston
Avila Shows Progress in Covalent Cancer Drugs at Prominent ASH Confab 12/12/11 Boston
Aileron CEO Hails Expanded Roche Deal as a Validation of Stapled-Peptide Drug Technology 11/17/11 Boston
Agios Nabs $78M From Partner Celgene, Existing VCs, and Public Funds 11/17/11 Boston
BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs 10/27/11 Boston
Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage 10/11/11 Boston
Xconomist of the Week: Pfizer’s Barbara Dalton to Speak at Our NY Life Sciences 2031 Forum 09/29/11 New York
RXi Splits Into Two Public Companies After Adding Cancer Vaccine to Pipeline 09/26/11 Boston
Page 1 of 2 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.